HIV INFECTION CDC GROUP III side effect
What is HIV INFECTION CDC GROUP III ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
HIV INFECTION CDC GROUP III and Recently Reported Side Effects
HIV INFECTION CDC GROUP III and 15 most Active Side Effect polls
HIV INFECTION CDC GROUP III and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with HIV INFECTION CDC GROUP III
KALETRAKaletra Side Effects Report #5612842-5
Consumer or non-health professional from CHILE reported KALETRA problem on Jan 30, 2008. Female patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cachexia, hiv infection cdc group iii, pulmonary sepsis, pyrexia, respiratory distress, respiratory failure, treatment noncompliance, . KALETRA dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, TENOFOVIR DISOPROXIL FUMARATE. Patient died on 01/22/2008.
Kaletra Side Effects Report #5632201-9
KALETRA problem was reported by a Consumer or non-health professional from CHILE on Feb 11, 2008. Female patient, weighting 108.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cachexia, hiv infection cdc group iii, immunosuppression, pulmonary sepsis, pyrexia, respiratory distress, respiratory failure, treatment noncompliance, . KALETRA dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, TENOFOVIR DISOPROXIL FUMARATE. Patient died on 01/22/2008.